← Open Payments lookup

LAURA SEIGLE KERR: Open Payments

NPI 1215913991 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,240 in 59 payments from 11 companies in 2025. Trend: 2023 $641 · 2024 $1,825 · 2025 $1,240

Food & beverage: $1,240
CompanyPaymentsAmount
GENZYME CORPORATION7$202
Ardelyx, Inc.8$181
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$171
Janssen Biotech, Inc.3$161
ABBVIE INC.7$149
Celltrion USA Inc.5$108
Takeda Pharmaceuticals U.S.A., Inc.5$107
Lilly USA, LLC3$70
Aimmune Therapeutics, Inc.2$41
Ipsen Biopharmaceuticals, Inc2$38

Products named: DUPIXENT, IBSRELA, TREMFYA, XIFAXAN, VEGZELMA, OMVOH, LINZESS, RINVOQ.

Industry payments across TX — which companies pay providers there.